NEW YORK (GenomeWeb News) – Beckman Coulter Life Sciences on Thursday announced the acquisition of the flow cytometry business assets of ReaMetrix India for an undisclosed amount.

Beckman Coulter LS said that the deal provides it with "temperature-stable, single-dose, multicolor antibody cocktails targeting the HIV monitoring and clinical research markets." It added that ReaMetrix's products complement its flow cytometry product portfolio with reagents that streamline the sample preparation process and provide standardized reagent combinations to cytometry labs.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: GWAS links gene to noise-induced hearing loss in mice, population genetics of malaria parasites, and more.

Nautilus' Alexandra Ossola examines how Tay-Sachs disease jump-started the genetic disease testing field.

FASEB says guidelines proposed by the NIH to bolster research reproducibility are premature and don't take the full range of scientific studies into consideration.

Liquid biopsies and DNA tests may be able to tell physicians whether a cancer patient is relapsing, the New York Times reports.